AC Health gets antitrust body's approval to raise stake in Generika
Featured:
|
ADVERTISEMENT
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
AC Health gets antitrust body's approval to raise stake in Generika
ABS-CBN News
Published Jun 04, 2019 11:10 AM PHT
MANILA - Ayala Corp on Tuesday said the Philippine Competition Commission approved the plan of its subsidiary, Ayala Healthcare Holdings, to increase its stake in Generika group.
MANILA - Ayala Corp on Tuesday said the Philippine Competition Commission approved the plan of its subsidiary, Ayala Healthcare Holdings, to increase its stake in Generika group.
AC Health will proceed with raising its stake in Generika to 52.5 percent from 50 percent after receiving approval from the PCC last June 3, Ayala Corp said in a disclosure to the stock exchange.
AC Health will proceed with raising its stake in Generika to 52.5 percent from 50 percent after receiving approval from the PCC last June 3, Ayala Corp said in a disclosure to the stock exchange.
The transaction involves Generika's Actimed Inc, Novelis Solutions Inc and Pharm Gen Ventures Corp.
The transaction involves Generika's Actimed Inc, Novelis Solutions Inc and Pharm Gen Ventures Corp.
Changes in Generika's Erikagen Inc is still subject to conditions, Ayala said.
Changes in Generika's Erikagen Inc is still subject to conditions, Ayala said.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
